NEW YORK (GenomeWeb) – Pressure Biosciences reported yesterday a nearly 8 percent drop in third quarter revenues as increased instrument sales failed to offset a decline in grant revenues.

For the three-month period ended Sept. 30, Pressure's revenues fell to $535,334 from $580,334 in the same quarter last year. Instrument sales were up nearly 13 percent to $383,789 from $340,084 a year ago, but the increase was  more than offset by a decline in grant revenues to $34,385 from $98,882.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.